Biography:
Li Su is an accomplished molecular epidemiologist and Lab Director at the Harvard T.H. Chan School of Public Health. With expertise in lung cancer susceptibility, she has authored over 160 publications. Her first-author research includes investigating matrix metalloproteinase-1 promoter polymorphisms and the association of p21 and p53 genotypes with lung cancer risk. Li received the Harvard ACE Award. She currently leads laboratory operations, training doctoral students in advanced molecular techniques for international oncology research.
Title : Identification of prognostic biomarkers and potential therapeutic targets for lung cancer by metabolomics analysis